Knowledge of Chronic Kidney Disease Among Liver Transplant Recipients by Park, Jeong M. et al.
This is the author manuscript accepted for publication and has undergone full peer review but has 
not been through the copyediting, typesetting, pagination and proofreading process, which may 
lead to differences between this version and the Version of Record. Please cite this article as doi: 
10.1002/lt.25302 




Article type      : Letters from the Frontline 
 
 
Knowledge of Chronic Kidney Disease among Liver Transplant Recipients 
 
Jeong M. Park Pharm D1, Claire Koerschner, BS2, Jennifer Mawby, RN2
Sara Selman, PharmD
,  
1, Hellan K Kwon, MD3, Christopher J Sonnenday, MD2
Julie A Wright Nunes, MD
,  
4, Pratima Sharma, MD
 
3 
1College of Pharmacy 
2Division of Transplantation Surgery  
3Division of Gastroenterology and Hepatology 
4
University of Michigan, Ann Arbor, MI 48109 
Division of Nephrology 
 
Corresponding Author: 
Pratima Sharma, MD, MS 
Associate Professor 
Division of Gastroenterology and Hepatology 
Michigan Medicine, University of Michigan 
3912, Taubman Center 
1500 East Medical Center Dr. 



















Acknowledgement: The authors declare no conflicts of interest.  This work, in part, 
presented at American Transplant Congress’ 2017 held in Chicago, Illinois in April 2017. 
This work was supported by University of Michigan MCUBED 2.0 mini cube grant.  
 
Abbreviations:  
Body Mass Index     BMI  
Blood Pressure     BP 
Confidence Interval      CI 
Chronic Kidney Disease    CKD     
estimated Glomerular Filtration Rate  eGFR 
End Stage Renal Disease    ESRD   
Hazard Ratio      HR     
Hemoglobin A1C     HbA1C 
Kidney Disease Knowledge Survey   KiKS    

























This article is protected by copyright. All rights reserved 
To the editors:  
 Chronic kidney disease (CKD) after liver transplant (LT) is an important co-
morbidity that negatively affects  patient and graft survival.1,2 Additionally, it adds to 
resource utilization in  LT recipients leading to increased  healthcare costs.1-4 Although 
LT recipients have established framework of care and access to education as a part of 
transplant process, there may be significant modifiable gaps in their knowledge and 
understanding of CKD after LT.  
Wright et al. developed a reliable and validated instrument called Kidney Disease 
Knowledge Survey (KiKS) that identified the areas of and risk factors for poor kidney 
knowledge in the non-transplant CKD population.5 To assess the CKD knowledge 
among LT recipients, we modified the KiKS survey by adding four LT specific questions 
to the KiKS and performed the face validity and content validity before administering the 
survey to the study cohort.  The KiKS-LT survey examined the CKD knowledge in the 
following domains: 1) general knowledge of kidney disease; 2) LT-specific kidney and 
immunosuppression knowledge; 3) knowledge of kidney function; and 4) knowledge of 
symptoms of CKD progression or kidney failure.  
 
Materials and Methods  
Study Design and Population:  
 We conducted a cross-sectional survey study among LT recipients who had a 
routine post-LT appointment at the University of Michigan liver transplant outpatient 
clinics between July 1, 2016 and September 30, 2017. The subjects were followed up 
until May 31, 2018. Our study included the recipients of LT between January 1, 2008 
and December 31, 2016, age ≥18 years, ≥3 months post-LT; estimated glomerular 
filtration rate (eGFR) ≥30 ml/min at the time of survey. We excluded the recipients of 
kidney transplant at or after LT, eGFR <30 ml/min, on dialysis or listed for kidney 
transplant. Our Institution Review Board approved the study.   
 
KiKS-LT Survey Instrument:  
After a content review of CKD knowledge questionnaire in general population, we 
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questions to KiKS. The KiKS-LT survey comprised of thirty-one questions 
(Supplemental material) with one best answer. We asked additional questions at the 
end of KiKS-LT survey from the respondents: Do you use the Patient Portal your 
electronic health record? 2) How would you like to receive CKD educational and goal 
setting tool, if interested in learning more about CKD? 
 To establish the face-validity, content validity and construct validity of KiKS-LT 
survey, we convened experts in various areas of LT and CKD care [transplant provider 
with expertise in liver disease, kidney disease and transplant surgery (n=4), nurses 
(n=2), research personnel (n=2) and transplant pharmacists (n=2)]. We also solicited 
method input from experts in health literacy, scale validation, and psychometric 
analysis. We used the Kuder-Richardson-20 coefficient (KR-20) to determine internal 
consistency.  
 
Statistical Analysis:  
 Continuous and categorical variables were expressed as median and 
interquartile range (IQR) and percentage, respectively. eGFR was calculated using the 
4-variable Modification of Diet in Renal Disease Study (MDRD) equation. CKD stage 
was assigned based on KDOQI guidelines. Z-test was used to compare the distribution 
of CKD knowledge scores of LT recipients with the distribution of CKD knowledge 
scores in non-transplant recipients (Wright et al.5).  The main outcome was CKD 
knowledge score, calculated as the proportion of all correct answers on the KiKS-LT 
survey by each subject. We used linear regression to examine the associations 
between CKD knowledge and patient characteristics (age, education level, CKD stage 
and diabetes). Exploratory analyses were performed for gender, etiology, seen by 
nephrologist and time from LT to survey. Multi-collinearity of the covariates was tested 
using tolerance and variance inflation factors.   
Cox regression was used to examine the effect of CKD knowledge on CKD 
progression to stage 4-5 CKD during the follow up period. The time to event was 
calculated from date of survey to the date of event or end of follow up period. The model 
was adjusted for age at survey, decile of knowledge score, diabetes, answering ‘yes’ to 
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We performed all statistical analyses using SPSS, version 24 (IBM Corp., 
Armonk, NY).  
 
Results 
After obtaining the informed consent, the KiKS-LT survey was administered to 
175 subjects. One withdrew consent, and 11 did not return the survey. The final study 
cohort consisted of 163 LT recipients (Table 1).  More than half of the respondents 
(55%) were actively using patient portal messaging through electronic health records. 
Sixty-five percent of those who responded ‘yes’ interested in learning more about CKD 
in LT recipients through an educational tool. Three fourths of those interested in 
learning more about CKD wanted to be contacted either via patient portal of electronic 
health record or via telephone.    
The median eGFR at the time of survey was 57.7 ml/min. More than half had 
stage 3 CKD. Only 14% had seen a nephrologist. The prevalent risk factors for CKD like 
diabetes, hypertension and obesity were present in 26%, 42% and 40% of the 
respondents, respectively.  The median time from LT to survey was 2.7 years (IQR: 1.1-
6.1 years). Median time from survey to last follow up was 16 months (IQR: 14-17 
months).  
 
Primary and Secondary Outcomes: 
The 31-question KiKS-LT survey was analyzed for internal consistency (Kuder-
Richardson 20= 0.769). Table 2 shows the degree of difficulty and item correlation. The 
mean knowledge score defined as proportion correct answer of KiKS-LT survey was 
0.60 [95% CI:0.57-0.63]. The CKD knowledge score among LT recipients with stage 1-3 
CKD was significantly lower compared to the non-LT CKD population surveyed by 
Wright et al. using KiKS (0.66 [95% CI, 0.65-0.67])5.  
 
Independent Predictors of CKD Knowledge among LT Recipients:   
Figure 1 showed the spread of eGFR within each decile of CKD knowledge 
score. In an adjusted analysis, younger age (β=-0.003 per year decrease in age; 
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survey were associated with high CKD knowledge. Education above high school and 
diabetes were independently associated with 8.3% (p=0.002) and 7.7% (p=0.01) 
increase, respectively, in the CKD knowledge.  
 
Progression to Advanced CKD and Predictors: 
 Nine patients progressed to stage 4-5 CKD after the median follow up of 16 
months (IQR: 14-17 months) from the date of survey. As expected, eGFR at the time of 
survey (HR=0.92 [95% CI 0.86-0.99]; p=0.02) was the independent predictor of stage 4-
5 CKD. Those who answered “yes” to more CKD education trended towards lower risk 
of advanced CKD (p=0.14) compared to those who responded “no”.  
 
Discussion 
 This is the first study to examine the CKD knowledge among LT recipients with 
stage 1-3 CKD using modified KiKS-LT survey. The distribution of CKD knowledge 
scores among LT recipients was lower than the distribution of those with CKD in non-LT 
population. Only 14% had established nephrology care in our cohort. This may be 
because majority had early stage CKD (eGFR>45 ml/min).   
 We also showed that presence of diabetes and high CKD stage were associated 
with higher CKD knowledge among LT recipients.  
The majority of participants were aware that calcineurin inhibitors are a risk factor 
of CKD.  Interestingly, time from LT to survey was not associated with the patient’s level 
of CKD knowledge. This finding suggests that educational programs are needed for LT 
recipients regardless of transplant duration.  
Our study indicates that CKD knowledge among LT recipients is low and may be 
a barrier for self-care. Encouragingly, more than two thirds of the LT recipients were 
interested in learning more about CKD progression and prevention. The majority 
indicated that they would like to get the education remotely instead of at their clinic visit.  
Many studies have addressed the burden of post-LT CKD progression.1-3  
In conclusion, the results of this study will facilitate evidence-based development 
of a personalized CKD education and goal-setting tool for LT recipients with early 
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Figure 1: Distribution of eGFR at the time of survey within each decile of CKD 
knowledge score  
 
Footnote: The ends of the box are the upper and lower quartiles, so the box spans the 
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Table 1: Characteristics of LT recipients at the time of survey (n=163) 
Characteristics at Survey Median (IQR) or N (%) 
Age at survey (years) 60 (51-64) 
Male gender 117 (71.3%) 
Race 
   Caucasians 
   African Americans 
   Hispanics 
   Asians 







Etiology of liver disease 
   Hepatitis C 
   Alcoholic liver disease 
   Cryptogenic cirrhosis/NAFLD 
   Autoimmune/PBC/PSC 







HCC  43 (26.4%) 
Time from LT to survey 2.7 years (1.1-6.1) 
Serum Creatinine  
eGFR  
  Stage 1 CKD 
  Stage 2 CKD 
  Stage 3 CKD 
Established Nephrology Care 
1.2 mg/dl (1.0-1.4) 





BMI at survey 
  <25 
  25-29 
  30-34 








137 mmHg (125-150) 





















  High school or less 
  Some college or completed college 
  Grad school or higher 






Use patient portal of electronic health record 92 (56.4%) 
Interested in education 
  via phone 
  patient portal  





Footnote: BMI, body mass index; BP, blood pressure; CKD, chronic kidney disease; HCC, 
hepatocellular carcinoma; IQR, interquartile range; LT, liver transplantation; NAFLD, non-
alcoholic fatty liver disease; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis 
Table 2: Degree of difficulty and item correlation grouped by the domains 
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• Understanding the risk factors of CKD 
• Understanding increased risk of heart disease 
• Understanding increased risk of mortality 
• Definition of GFR 
• Knowing there are stages of CKD 
• Medications a person with CKD should avoid 
• Medications important to kidney health 
• Treatment options for kidney failure 
• Understanding BP goals 
• Definition of HbA1C 

























LT-specific kidney and immunosuppression knowledge 
• Understanding that risk of CKD is increased 
• Understanding side effects of calcineurin inhibitors 
• Immunosuppression and graft health 












Knowledge of Kidney function 
• Role in glucose control 
• Role in bone health 
• Role in anemia 
• Role in hair loss 
• Role in BP control 
• Urine production 


















Knowledge of symptoms CKD progression or failure 
• No symptoms 
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• Metallic/bad taste 
• Shortness of breath 
• Increased fatigue 
• Hair loss 
• Difficulty sleeping 
• Weight loss 
47% 
41% 
80% 
76% 
61% 
45% 
0.38 
0.42 
0.58 
0.46 
0.44 
0.37 
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